“…Xenograft bone substitutes, derived from non-human species, were first introduced utilizing bovine bones in 1957. Although offering osteoconductive properties at a lower cost, xenografts bear the caveat of potential transmission of animal-borne diseases [ 29 , 30 ]. Notably, contemporary treatment strategies have embraced the induction membrane technique, notably the Masquelet technique, for addressing substantial bone defects.…”